WO2011036479A2 - Process and catalyst - Google Patents

Process and catalyst Download PDF

Info

Publication number
WO2011036479A2
WO2011036479A2 PCT/GB2010/051583 GB2010051583W WO2011036479A2 WO 2011036479 A2 WO2011036479 A2 WO 2011036479A2 GB 2010051583 W GB2010051583 W GB 2010051583W WO 2011036479 A2 WO2011036479 A2 WO 2011036479A2
Authority
WO
WIPO (PCT)
Prior art keywords
molybdenum
compound
phosphorus
catalyst
molar ratio
Prior art date
Application number
PCT/GB2010/051583
Other languages
French (fr)
Other versions
WO2011036479A3 (en
Inventor
Rhony Niklaus Aufdenblatten
Thomas Peter Belser
Wilhelm Quittmann
Original Assignee
Astrazeneca Ab
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN1942DEN2012 priority Critical patent/IN2012DN01942A/en
Priority to BR112012006491A priority patent/BR112012006491B1/en
Priority to MX2012003567A priority patent/MX2012003567A/en
Priority to AU2010299665A priority patent/AU2010299665B2/en
Priority to CA2773617A priority patent/CA2773617C/en
Priority to JP2012530339A priority patent/JP5931731B2/en
Priority to SG2012014122A priority patent/SG178601A1/en
Priority to RU2012116047/04A priority patent/RU2538277C2/en
Application filed by Astrazeneca Ab, Astrazeneca Uk Limited filed Critical Astrazeneca Ab
Priority to CN2010800415391A priority patent/CN102574105A/en
Priority to ES10759961T priority patent/ES2881677T3/en
Priority to EP10759961.5A priority patent/EP2480330B1/en
Publication of WO2011036479A2 publication Critical patent/WO2011036479A2/en
Publication of WO2011036479A3 publication Critical patent/WO2011036479A3/en
Priority to IL218348A priority patent/IL218348A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/14—Phosphorus; Compounds thereof
    • B01J27/185—Phosphorus; Compounds thereof with iron group metals or platinum group metals
    • B01J27/1856—Phosphorus; Compounds thereof with iron group metals or platinum group metals with platinum group metals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/18—Carbon
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/652—Chromium, molybdenum or tungsten
    • B01J23/6525—Molybdenum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/14—Phosphorus; Compounds thereof
    • B01J27/186—Phosphorus; Compounds thereof with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J27/188—Phosphorus; Compounds thereof with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium with chromium, molybdenum, tungsten or polonium
    • B01J27/19—Molybdenum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
    • B01J37/28—Phosphorising
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
    • C07C209/32—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups
    • C07C209/36—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups by reduction of nitro groups bound to carbon atoms of six-membered aromatic rings in presence of hydrogen-containing gases and a catalyst
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Abstract

Aromatic or heteroaromatic nitro compounds are catalytically hydrogenated to the corresponding amines in the presence of a platinum catalyst comprising elemental platinum on a support; the platinum catalyst is modified with a molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5, e.g. hypophosphorous acid; the catalyst is particularly useful in the hydrogenation of nitro compounds with halogen and/or sulfur-containing substituents.

Description

PROCESS AND CATALYST
The invention relates to a process for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds to the corresponding amines. It further relates to a modified supported platinum catalyst containing molybdenum and phosphorus.
The reduction of aromatic and heteroaromatic nitro compounds provides an important synthetic route to the corresponding amines. However, the reaction proceeds over several intermediates and it is sometimes difficult to achieve a complete reduction. In particular the hydroxylamine intermediate often poses a problem since it is relatively stable and may accumulate in the reaction mixture. When the reduction is carried out via catalytic hydrogenation, other reducible substituents, such as halogen atoms or groups containing carbon-carbon multiple bonds, or sulfur-containing groups (e.g. thioether groups) can cause unwanted side reactions (e.g. hydrogenolysis or hydrogenation of carbon-carbon multiple bonds) or inhibition effects ("catalyst poisoning"), which result in formation of undesired byproducts, unsatisfactory yields, or the requirement of uneconomically large amounts of catalyst. It has been an objective of the present invention to provide a method for the selective reduction of aromatic and heteroaromatic nitro compounds to the corresponding amines that gives good yields even in the presence of halogen or oxygen- containing or sulfur-containing substituents without requiring drastic reaction conditions or unreasonably large amounts of catalyst.
According to the invention, this objective has been achieved by the processes and the catalysts described herein. It has been found that the performance of a supported platinum catalyst in the hydrogenation of an aromatic or heteroaromatic nitro compound to the corresponding amine can be substantially improved by modifying it with a
molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5.
In particular, the invention provides a process for the catalytic hydrogenation of an aromatic or heteroaromatic nitro compound to the corresponding amine in the presence of a platinum catalyst comprising elemental platinum on a support, characterized in that the platinum catalyst has been modified with a molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5. In particular, the phosphorus compound is hypophosphorous acid or a salt or reaction product thereof and the molybdenum compound is an orthomolybdate or reaction product thereof (for example, ammonium orthomolybdate or zinc orthomolybdate or a reaction product thereof).
In particular, the invention provides a process wherein the aromatic or
heteroaromatic nitro compound is substituted with one or more substituents selected from the group consisting of halogen atoms and oxygen-containing or sulfur-containing groups; especially the group consisting of halogen atoms and sulfur-containing groups.
In particular, the present invention concerns a process for the preparation of 5- aminopyrimidines which are useful intermediates in the preparation of pharmaceutically active triazolo[4,5-d]pyrimidine cyclopentanes.
The compound [lS-(lcc, 2a, 3β (l^,2i?!i:),5 )]-3-[7-[2-(3,4-difluorophenyl)- cyclopropyl]amino]-5-(propylthio)-3H-l,2,3-triazolo[4,5-(i]pyrimidin-3-yl)-5-(2- hydroxyethoxy)-cyclopentane-l,2-diol (Compound A), and similar such compounds, are disclosed in WO 00/34283 and WO 99/05143 as pharmaceutically active Ρ2χ (which is now usually referred to as P2Yi2) receptor antagonists. Such antagonists can be used as, inter alia, inhibitors of platelet activation aggregation or degranulation.
Figure imgf000003_0001
HO OH
Compound A
Compounds of formula (I) (see below) are useful in the preparation of Compound A and analogues thereof (see Example 3 of WO 01/92263).
In particular, the present invention provides a process for the preparation of a compound of formula (I):
Figure imgf000004_0001
wherein X is halogen; Y is ZR1; Z is oxygen or sulphur; and R1 is Ci_6 alkyl, Ci_6 haloalkyl or C3_7 cycloalkyl; the process comprising hydrogenation in a suitable solvent of a nitro compound of formula (II)
Figure imgf000004_0002
in the presence of a supported platinum catalyst according to the invention.
In particular, the present compound of formula (II) is 4,6-dichloro-5-nitro-2- (propylthio)-pyrimidine (also named 4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine).
The modified catalysts according to the invention can be easily prepared and activated. It is therefore possible to prepare them fresh before use, thus ensuring maximum activity. The process of the invention may be used to hydrogenate both mononitro compounds and compounds having two or more nitro groups.
In a preferred embodiment the phosphorus compound is hypophosphorous acid (H3PO2) or a salt thereof, such as sodium or calcium hypophosphite, or a reaction product of said acid or salt. The term "reaction product" is to be understood to mean any product resulting from a chemical reaction of said acid or salt with the platinum catalyst or the molybdenum compound, with hydrogen, or with the aromatic or heteroaromatic nitro compound or its hydrogenation products.
In another preferred embodiment the molybdenum compound is an orthomolybdate or dimolybdate (i.e., a salt containing the Mo O^" or IVk^ Oy " anion) or a polymolybdate (e.g. a salt containing the M07 O24 anion), or a reaction product thereof. The term "reaction product" is to be understood to mean any product resulting from a chemical reaction of said molybdate with the platinum catalyst or the phosphorus compound, with hydrogen, or with the aromatic or heteroaromatic nitro compound or its hydrogenation products. Especially preferred are orthomolybdates, in particular ammonium orthomolybdate ((NH4)2Mo04) or zinc orthomolybdate (ZnMo04).
The support (carrier) of the platinum catalyst may be any usual carrier including, but not limited to, alumina, silica and charcoal (activated carbon), charcoal being preferred.
The process of the invention is particularly suited to the hydrogenation of nitro compounds which are substituted with one or more substituents selected from the group consisting of halogen atoms and sulfur-containing groups, such as alkylthio (alkylsulfanyl, thioether) groups. Said substituents will not interfere with the reduction of the nitro group(s) by causing unwanted side reactions or catalyst poisoning.
More preferably the process is employed for the hydrogenation of heteraromatic nitro compounds such as nitropyridines or nitropyrimidines, the latter being particularly preferred.
A specifically preferred heteroaromatic nitro compound is 4,6-dichloro-5-nitro- 2-(propylsulfanyl)pyrimidine which can be reduced to 5-amino-4,6-dichloro-2-(propyl- sulfany l)pyrimidine .
The modified supported platinum catalyst containing molybdenum and a phosphorus compound, wherein the phosphorus has an oxidation state of less than +5, can be obtained by treating a supported platinum catalyst with an aqueous solution of hypo- phosphorous acid or a salt thereof and an orthomolybdate.
The molybdenum/platinum molar ratio is advantageously in the range of 1 : 1 to 100: 1 , preferably in the range of 1 : 1 to 10: 1 and most preferably in the range of 1 : 1 to 5 : 1 , while the phosphorus/molybdenum molar ratio is advantageously in the range of 1 : 1 to 100: 1 , preferably in the range of 1 : 1 to 10: 1 and most preferably in the range of 1 : 1 to 5 : 1.
A suitable solvent for the hydrogenation of a compound of formula (II) is water, a Ci_6 aliphatic alcohol (such as ethanol and iso-propyl alcohol), an ether (for example a di(Ci_6 alkyl) ether, such as diethylether or methyl tert-butyl ether; or a cyclic ether such as tetrahydrofuran), an ester (for example ethyl acetate) or a hydrocarbon solvent (such as an aromatic hydrocarbon, for example benzene, toluene or a xylene). Appropriate mixtures of such solvents may also be used.
In another aspect the hydrogenation of a compound of formula (II) is conducted at a temperature in the range 10 to 90°C. In yet another aspect the hydrogenation of a compound of formula (II) is conducted at a pressure of 1 to 10 bar.
The following non-limiting examples will further illustrate the invention and its preferred embodiments.
Example 1: Catalyst preparation
To a slurry of 4.6 g of a commercial platinum on charcoal catalyst (5% Pt, Engelhard type 18, 40.5 weight% wet, lot #12410) in water (38 g), an aqueous solution of hypophosphorous acid (50%, 0.44 g, 3.4 mmol) was added and stirred for 15 minutes at 20 °C. After this, ammonium orthomolybdate ((NH4)2Mo04, 0.27 g, 1.4 mmol; molar ratio H3P02/(NH4)2Mo04 = 2.4: 1; molar ratio (NH4)2Mo04/Pt = 2: 1) was added to the slurry which was stirred vigorously over a period of 15 min and then transferred to the hydrogenation autoclave. The flask and the transfer line were flushed with tert-butyl methyl ether (31 g). The measured pH of the aqueous phase was 2.3 and the molybdenum content was 123 ppm.
Example 2: 5-Amino-4,6-dichloro-2-propylsulfanylpyrimidine
tert-Butyl methyl ether (370 g) was placed under nitrogen in a 1 L stainless steel autoclave equipped with a temperature-controlled jacket, an Ekato InterMIG® stirrer, an internal temperature sensor and a dip pipe, and 4,6-dichloro-5-nitro-2-propylsulfanyl- pyrimidine (94.5 g, 0.35 mol) was added and dissolved at a stirring rate of 200 min 1.
The catalyst suspension was prepared and transferred into the autoclave as described in the preceding example. The autoclave was sealed and the stirring rate was increased to 600 min 1 while the autoclave was purged four times with nitrogen. Subsequently, hydrogen gas feed via the dip pipe at a constant flow rate (pmax = 10 bar) as well as a heating-up ramp (45 K/h) from 20 °C to 65 °C were started in parallel, while stirring at 600 min 1. The progress of the exothermic reaction was followed by recording the hydrogen uptake as well as the internal and jacket temperature curve. Upon completion of the hydrogen uptake (ca. 1.1 mol or 3 molar equivalents) after about 4 h, stirring of the reaction mixture was continued for an additional 3 hours at 65 °C. After unloading the autoclave (the reactor was cooled down to 20 °C, the hydrogen pressure was released and the reactor purged four times with nitrogen), the catalyst was filtered off. The autoclave as well as the filter cake (catalyst) were washed with tert-butyl methyl ether (185 g). The organic phases were combined and the water layer separated. An IPC-sample was taken to analyze the product mixture.
The conversion was found to be quantitative with no nitroso or hydroxylamine intermediate being detectable.
1H NMR (CDC13, 400 MHz): δ 4.24 (br. s, 2H), 3.08 (t, J= 7.2 Hz, 2H), 1.74 (sex , J= 7.2 Hz, 2H), 1.02 (t, J= 7.2 Hz, 3H).
Comparative Example 1: (Unmodified Pt/C catalyst)
tert-Butyl methyl ether (370 g) was placed under nitrogen in a 1 L stainless steel autoclave equipped with a temperature-controlled jacket, an InterMIG® stirrer, an internal temperature sensor and a dip pipe. 4,6-Dichloro-5-nitro-2-propylsulfanylpyrimidine (94.5 g, 0.35 mol) was added and dissolved at a stirring rate of 200 min-1. The autoclave was purged four times with nitrogen (stirring rate: 600 min 1).
A slurry of the catalyst was prepared in a separate flask as follows: A commercial platinum on charcoal catalyst (4.6 g, 5% Pt, Engelhard type 18, 40.5 weight% wet, lot #12410; S/C=500: l) in water (38 g, 2.1 mol) was stirred for 15 min at 20 °C (the measured pH of the aqueous phase was 7.4). The resulting catalyst suspension was transferred into the autoclave and the flask and the transfer line were washed with tert-butyl methyl ether (31 g, 0.35 mol). The autoclave was then sealed and purged four times with nitrogen (stirring rate: 600 min 1).
Subsequently, the dosage of the hydrogen gas via dip pipe with a constant flow rate (Pmax = 10 bar) as well as the heating-up ramp (45 K/h) to 65 °C was started in parallel, while stirring at 600 min 1. The progress of the exothermic reaction was followed by measuring the hydrogen uptake as well as the internal and jacket temperature curve. After completion of the hydrogen uptake, the stirring (600 min 1) of the reaction mixture was continued for an additional 3 h at 65 °C.
After unloading the autoclave (the reactor was cooled down to 20 °C, the ¾- pressure was released and the reactor purged four times with nitrogen), the catalyst was filtered off. The autoclave as well as the filter cake (catalyst) was washed with tert-butyl methyl ether (185 g, 2.10 mol). The organic phases were combined and the water layer separated. An IPC-sample was taken to analyze the product mixture. Yield: 79%.

Claims

Claims
1. A process for the catalytic hydrogenation of an aromatic or heteroaromatic nitro compound to the corresponding amine in the presence of a platinum catalyst comprising elemental platinum on a support, characterized in that the platinum catalyst has been modified with a molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5.
2. The process of claim 1, wherein the phosphorus compound is hypophosphorous acid or a salt or reaction product thereof.
3. The process of claim 1 or 2, wherein the molybdenum compound is an ortho- molybdate or reaction product thereof.
4. The process of claim 3, wherein the molybdenum compound is ammonium ortho- molybdate or zinc orthomolybdate or a reaction product thereof.
5. The process of any one of claims 1 to 4, wherein the support is charcoal.
6. The process of any one of claims 1 to 5, wherein the catalyst has a molybdenum/platinum molar ratio of 1 : 1 to 100: 1 and a phosphorus/molybdenum molar ratio of 1 : 1 to 100: 1.
7. The process of claim 6, wherein the catalyst has a molybdenum/platinum molar ratio of 1 : 1 to 10: 1 and a phosphorus/molybdenum molar ratio of 1 : 1 to 10: 1.
8. The process of any one of claims 1 to 7 wherein the aromatic or heteroaromatic nitro compound is substituted with one or more substituents selected from the group consisting of halogen atoms and oxygen-containing or sulfur-containing groups.
9. The process of any one of claims 1 to 8 wherein the heteroaromatic nitro compound is a nitropyrimidine. The process of any one of claims 1 to 9 wherein the heteroaromatic nitro compound is a compound of formula (II)
Figure imgf000010_0001
wherein X is halogen; Y is ZR1; Z is oxygen or sulphur; and R1 is Ci_6 alkyl, Ci_6 haloalkyl or C3_7 cycloalkyl.
1 1. The process of claim 10 wherein the heteroaromatic nitro compound is 4,6-dichloro- 5 -nitro-2-(propylsulfanyl)pyrimidine .
12. A modified supported platinum catalyst containing molybdenum and a phosphorus compound, wherein the phosphorus has an oxidation state of less than +5, obtainable by treating a supported platinum catalyst with an aqueous solution of
hypophosphorous acid or a salt thereof and an orthomolybdate in a molybdenum/platinum molar ratio of 1 : 1 to 100: 1 and a phosphorus/molybdenum molar ratio of 1 : 1 to 100: 1.
13. The modified supported platinum catalyst of claim 12, wherein the molybdenum/platinum molar ratio is from 1 : 1 to 10: 1 and the phosphorus/molybdenum molar ratio is from 1 : 1 to 10: 1.
14. The modified supported platinum catalyst of claim 12 or 13, wherein the orthomolybdate is selected from ammonium orthomolybdate and zinc orthomolybdate.
PCT/GB2010/051583 2009-09-23 2010-09-21 Process and catalyst WO2011036479A2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SG2012014122A SG178601A1 (en) 2009-09-23 2010-09-21 Process and catalyst
MX2012003567A MX2012003567A (en) 2009-09-23 2010-09-21 Process and catalyst.
AU2010299665A AU2010299665B2 (en) 2009-09-23 2010-09-21 Process and catalyst
CA2773617A CA2773617C (en) 2009-09-23 2010-09-21 Process and catalyst
JP2012530339A JP5931731B2 (en) 2009-09-23 2010-09-21 Method and catalyst
IN1942DEN2012 IN2012DN01942A (en) 2009-09-23 2010-09-21
RU2012116047/04A RU2538277C2 (en) 2009-09-23 2010-09-21 Method and catalyst
BR112012006491A BR112012006491B1 (en) 2009-09-23 2010-09-21 process for preparing compound of formula (i)
CN2010800415391A CN102574105A (en) 2009-09-23 2010-09-21 Process and catalyst
ES10759961T ES2881677T3 (en) 2009-09-23 2010-09-21 A process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds
EP10759961.5A EP2480330B1 (en) 2009-09-23 2010-09-21 A process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds
IL218348A IL218348A (en) 2009-09-23 2012-02-27 Process and catalyst for hydrogenation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09012080.9 2009-09-23
EP09012080A EP2305376A1 (en) 2009-09-23 2009-09-23 Process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds

Publications (2)

Publication Number Publication Date
WO2011036479A2 true WO2011036479A2 (en) 2011-03-31
WO2011036479A3 WO2011036479A3 (en) 2012-02-02

Family

ID=41604325

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/051583 WO2011036479A2 (en) 2009-09-23 2010-09-21 Process and catalyst

Country Status (18)

Country Link
US (1) US8242044B2 (en)
EP (2) EP2305376A1 (en)
JP (1) JP5931731B2 (en)
KR (1) KR20120092108A (en)
CN (2) CN102574105A (en)
AR (1) AR078429A1 (en)
AU (1) AU2010299665B2 (en)
BR (1) BR112012006491B1 (en)
CA (1) CA2773617C (en)
ES (1) ES2881677T3 (en)
IL (1) IL218348A (en)
IN (1) IN2012DN01942A (en)
MX (1) MX2012003567A (en)
MY (1) MY159144A (en)
RU (1) RU2538277C2 (en)
SG (1) SG178601A1 (en)
TW (1) TWI518054B (en)
WO (1) WO2011036479A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014023681A1 (en) * 2012-08-06 2014-02-13 Enantia, S.L. A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside
EP2705902A1 (en) 2012-09-06 2014-03-12 Allessa Chemie GmbH Method for hydrating nitro-aromatics with selected platinum catalysts

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014206187A1 (en) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 Preparation method of ticagrelor and intermediates thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005143A1 (en) 1997-07-22 1999-02-04 Astra Pharmaceuticals Ltd. Novel compounds
WO2000034283A1 (en) 1998-12-04 2000-06-15 Astrazeneca Ab Novel triazolo(4,5-d)pyrimidine compounds
WO2001092263A1 (en) 2000-06-02 2001-12-06 Astrazeneca Ab Novel triazolo pyrimidine compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB803261A (en) * 1954-03-20 1958-10-22 Basf Ag Improvements in treating hydrocarbons in the presence of hydrogen and in producing alumina for use as a carrier
US2932626A (en) 1956-06-01 1960-04-12 Union Carbide Corp Diepoxide polymers
US3953509A (en) * 1972-10-10 1976-04-27 Koppers Company, Inc. Hydrogenation of nitrobenzene to p-aminophenol
US4020107A (en) * 1975-04-07 1977-04-26 E. I. Du Pont De Nemours And Co. Catalytic reduction of halonitroaromatic compounds
CA1148562A (en) * 1979-02-22 1983-06-21 Alfred J. Bird Catalyst for the hydrogenation of halogen substituted aromatic nitro compounds
JPH05140008A (en) * 1991-11-21 1993-06-08 Daikin Ind Ltd Production of 1,3-dichloro-1,2,2,3,3-pentafluoropropane
IL128957A (en) * 1996-09-23 2005-11-20 Syngenta Participations Ag Process for the preparation of substituted aromatic amino compounds
JP2001198469A (en) * 1999-11-05 2001-07-24 Sekisui Chem Co Ltd Metal carrying catalyst for storing/supplying hydrogen and hydrogen storage/supply system using the catalyst
DE10048844A1 (en) * 2000-10-02 2002-04-11 Basf Ag Process for the production of platinum metal catalysts
JP2005144432A (en) * 2003-11-18 2005-06-09 Rohm & Haas Co Catalyst system for converting alkane into alkene and corresponding oxygenated product
SE0401001D0 (en) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
DE102006035203A1 (en) * 2006-07-29 2008-01-31 Bayer Materialscience Ag Process for the preparation of aromatic amines
JP5122178B2 (en) * 2007-04-27 2013-01-16 勝 市川 Supported catalyst for hydrogenation / dehydrogenation reaction, production method thereof, and hydrogen storage / supply method using the catalyst
US20100130788A1 (en) * 2007-05-10 2010-05-27 Basf Se Method for producing amines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005143A1 (en) 1997-07-22 1999-02-04 Astra Pharmaceuticals Ltd. Novel compounds
WO2000034283A1 (en) 1998-12-04 2000-06-15 Astrazeneca Ab Novel triazolo(4,5-d)pyrimidine compounds
WO2001092263A1 (en) 2000-06-02 2001-12-06 Astrazeneca Ab Novel triazolo pyrimidine compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014023681A1 (en) * 2012-08-06 2014-02-13 Enantia, S.L. A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside
EP2705902A1 (en) 2012-09-06 2014-03-12 Allessa Chemie GmbH Method for hydrating nitro-aromatics with selected platinum catalysts
US9452970B2 (en) 2012-09-06 2016-09-27 Allessa Gmbh Method for hydrogenating nitroaromatic systems with selected platinum catalysts

Also Published As

Publication number Publication date
TW201127786A (en) 2011-08-16
IN2012DN01942A (en) 2015-08-21
MY159144A (en) 2016-12-15
JP5931731B2 (en) 2016-06-08
CA2773617A1 (en) 2011-03-31
WO2011036479A3 (en) 2012-02-02
SG178601A1 (en) 2012-04-27
IL218348A0 (en) 2012-04-30
BR112012006491A2 (en) 2016-04-26
CA2773617C (en) 2017-10-10
JP2013505288A (en) 2013-02-14
CN102574105A (en) 2012-07-11
AU2010299665B2 (en) 2013-02-07
IL218348A (en) 2015-10-29
MX2012003567A (en) 2012-04-30
RU2012116047A (en) 2013-10-27
BR112012006491B1 (en) 2018-10-09
AU2010299665A1 (en) 2012-03-15
US8242044B2 (en) 2012-08-14
CN104941676A (en) 2015-09-30
KR20120092108A (en) 2012-08-20
EP2480330A2 (en) 2012-08-01
EP2305376A1 (en) 2011-04-06
EP2480330B1 (en) 2021-05-26
US20110071290A1 (en) 2011-03-24
AR078429A1 (en) 2011-11-09
TWI518054B (en) 2016-01-21
CN104941676B (en) 2018-06-08
RU2538277C2 (en) 2015-01-10
ES2881677T3 (en) 2021-11-30

Similar Documents

Publication Publication Date Title
EA021623B1 (en) Supported catalyst and method for producing an amine
US9914693B2 (en) Process for preparing EDA using SO2-free hydrocyanic acid
JP2009526801A (en) Process for producing ethyleneamine and ethanolamine from monoethylene glycol (MEG)
CN102803213B (en) Methyl-substituted TETA Compounds
WO2005095358A2 (en) Process for the preparation of aminopyrimidines
JP4159630B2 (en) Process for the preparation of N-substituted cyclic amines
EP0027022A1 (en) Production of five-membered nitrogen-containing saturated heterocyclic compounds and catalyst suitable therefor
AU2010299665B2 (en) Process and catalyst
JP4588848B2 (en) Process for producing pentanediol from alkoxydihydropyran
US20090270647A1 (en) Method for producing alpha - amino acid including phosphorus and production intermediates thereof
EP1268402B1 (en) Process for preparing 6-aminocaproamide
JP5152895B2 (en) Method for producing cyclic alkyleneimine
Ishitani et al. Catalytic hydrogenative dechlorination reaction for efficient synthesis of a key intermediate of SDHI fungicides under continuous-flow conditions
TW202039413A (en) Method for producing formic acid
KR860001085B1 (en) Process for preparing 2-alkyl-4-amino-5-aminomethyl pyridine
CN113416140B (en) Method for preparing 2-methyl pentanediamine
WO2002036559A2 (en) Process for the production of amides
JP4834217B2 (en) Production of heterocyclic nitriles
JP2013119522A (en) Method for producing 1-methylimidazole compound
JP2009137905A (en) Method for producing tertiary amine
JP2004083495A (en) Method for preparing 2-aminomethylpyrimidine and its salt

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080041539.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10759961

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010299665

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 218348

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 1942/DELNP/2012

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2773617

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2010299665

Country of ref document: AU

Date of ref document: 20100921

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012530339

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: MX/A/2012/003567

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2010759961

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20127008697

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012116047

Country of ref document: RU

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012006491

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012006491

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120322